Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The efficacy of everolimus and sunitinib in patients with sporadic or germline mutated metastatic pancreatic neuroendocrine tumors
Jose Eduardo Nuñez, Mauro Daniel Spina Donadio, Duilio Rocha Filho, et al.
Journal of Gastrointestinal Oncology (2019) Vol. 10, Iss. 4, pp. 645-651
Open Access | Times Cited: 17

Showing 17 citing articles:

Multiple Endocrine Neoplasia Type 1: Latest Insights
Maria Luisa Brandi, Sunita Agarwal, Nancy D. Perrier, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 2, pp. 133-170
Open Access | Times Cited: 146
<p>Von Hippel-Lindau Disease: Current Challenges and Future Prospects</p>
Sven Gläsker, Evelynn Vergauwen, Christian A. Koch, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 5669-5690
Open Access | Times Cited: 85
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects
Erika Stefàno, Federica De Castro, Antonella Ciccarese, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8568-8568
Open Access | Times Cited: 5
Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1
Francesca Marini, Francesca Giusti, Flavio Tonelli, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4041-4041
Open Access | Times Cited: 30
Safety and Efficacy of Peptide Receptor Radionuclide Therapy in Multiple Endocrine Neoplasia Syndrome: A Single-center Experience
Piyush Aggarwal, Swayamjeet Satapathy, Gurjeet Kaur, et al.
Clinical Nuclear Medicine (2025)
Closed Access
Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
Congxin Dai, Siyu Liang, Bowen Sun, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype–Phenotype Correlations
Przemysław Soczomski, Beata Jurecka‐Lubieniecka, Aleksandra Krzywon, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 16
Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies
Lingaku Lee, Irene Ramos-Álvarez, Robert T. Jensen
Cancers (2022) Vol. 14, Iss. 5, pp. 1250-1250
Open Access | Times Cited: 11
Non-Interventional Management of Advanced Pancreatic Neuroendocrine Neoplasms in Patients with von Hippel-Lindau Disease
Reut Halperin, Amit Tirosh
Cancers (2023) Vol. 15, Iss. 6, pp. 1739-1739
Open Access | Times Cited: 6
Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer
Ling Wei, Jujie Sun, Xingwu Wang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 6
Hereditary Syndromes in Neuroendocrine Tumors
Mark A. Lewis
Current Treatment Options in Oncology (2020) Vol. 21, Iss. 6
Closed Access | Times Cited: 14
Genetics of Pancreatic Neuroendocrine Tumors
Chirayu Mohindroo, Florencia McAllister, Ana De Jesus‐Acosta
Hematology/Oncology Clinics of North America (2022) Vol. 36, Iss. 5, pp. 1033-1051
Closed Access | Times Cited: 8
Assessing the effectiveness and safety of surufatinib versus everolimus or sunitinib in advanced neuroendocrine neoplasms: insights from a real-world, retrospective cohort study using propensity score and inverse probability treatment weighting analysis
Linhui Zhu, Xuan Ye, Youjun She, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 2, pp. 689-709
Open Access | Times Cited: 1
A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective
Silke D Werle, Nensi Ikonomi, Ludwig Lausser, et al.
npj Systems Biology and Applications (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 3
Effects of mTOR inhibitor, everolimus, on proliferation, autophagy and temozolomide sensitivity of glioma cells
Wei Dong, Jialiang Wang, Haipeng Liu, et al.
Tropical Journal of Pharmaceutical Research (2020) Vol. 19, Iss. 1, pp. 77-82
Open Access | Times Cited: 2
Multiple endocrine neoplasia type 1: a review of current diagnostic and treatment approaches
Francesca Marini, Francesca Giusti, Flavio Tonelli, et al.
Expert Opinion on Orphan Drugs (2020) Vol. 8, Iss. 9, pp. 367-377
Closed Access | Times Cited: 2
Pancreatic Neuroendocrine Tumors in Multiple Neoplasia Syndromes
Anja Rinke, Thomas M. Gress
Pancreas (2023), pp. 808-814
Open Access
Promising targetable biomarkers in pancreatic neuroendocrine tumours
Michele Borghesani, Lorenzo Gervaso, C.A. Cella, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 5, pp. 387-398
Closed Access
Page 1

Scroll to top